ResearcherCharles UniversityNo recent work listed
Jaroslav Macášek
Matched on ORCID iD 0000-0002-8009-8970; OpenAlex author ID A5032295726. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2011: 2 papers · 2012: 2 papers · 2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper
Papers 6
- Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis. Co-author DOI 10.3233/cbm-160617↗
- Antioxidant status and oxidative stress markers in pancreatic cancer and chronic pancreatitis. Co-author DOI 10.1097/mpa.0b013e318288360a↗
- Plasma fatty acid composition in patients with pancreatic cancer: correlations to clinical parameters. Co-author DOI 10.1080/01635581.2012.716138↗
- Paraoxonase-1 (PON1) status in pancreatic cancer: relation to clinical parameters. Co-author DOI 10.14712/fb2012058060231↗
- Leptin and adiponectin in pancreatic cancer: connection with diabetes mellitus. Co-author DOI 10.4149/neo_2011_01_58↗
- [Current status of pancreatic cancer diagnosis]. Co-author PMID 22292339↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Aleš Žák · 6 shared papers, 2011–2016 · strength 0.22
- Paper Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis. DOI 10.3233/cbm-160617↗
- Paper Antioxidant status and oxidative stress markers in pancreatic cancer and chronic pancreatitis. DOI 10.1097/mpa.0b013e318288360a↗
- Paper Plasma fatty acid composition in patients with pancreatic cancer: correlations to clinical parameters. DOI 10.1080/01635581.2012.716138↗
- T Krechler · 6 shared papers, 2011–2016 · strength 0.22
- Paper Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis. DOI 10.3233/cbm-160617↗
- Paper Antioxidant status and oxidative stress markers in pancreatic cancer and chronic pancreatitis. DOI 10.1097/mpa.0b013e318288360a↗
- Paper Plasma fatty acid composition in patients with pancreatic cancer: correlations to clinical parameters. DOI 10.1080/01635581.2012.716138↗
- M. Zeman · 4 shared papers, 2011–2016 · strength 0.15
- Paper Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis. DOI 10.3233/cbm-160617↗
- Paper Plasma fatty acid composition in patients with pancreatic cancer: correlations to clinical parameters. DOI 10.1080/01635581.2012.716138↗
- Paper Leptin and adiponectin in pancreatic cancer: connection with diabetes mellitus. DOI 10.4149/neo_2011_01_58↗
- Marek Vecka · 4 shared papers, 2011–2016 · strength 0.15
- Paper Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis. DOI 10.3233/cbm-160617↗
- Paper Plasma fatty acid composition in patients with pancreatic cancer: correlations to clinical parameters. DOI 10.1080/01635581.2012.716138↗
- Paper Leptin and adiponectin in pancreatic cancer: connection with diabetes mellitus. DOI 10.4149/neo_2011_01_58↗
- Jana Kodydková · 2 shared papers, 2012–2013 · strength 0.07
- Jana Rychlíková · 1 shared paper, 2016 · strength 0.06
- Lubos B. Petruzelka · 1 shared paper, 2012 · strength 0.03
- Tomáš Zima · 1 shared paper, 2011 · strength 0.03
- Jan Ulrych · 1 shared paper, 2011 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.